EUCTR2006-006026-25-DK进行中(未招募)不适用
Psoriasis Investigation of 4 different treatment regimes
Coloplast A/S, Consumer Products0 个研究点目标入组 24 人开始时间: 2006年12月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male or female age 18-65 years.
- •Generally physically mobile.
- •Willingness to sign an Informed Consent Form
- •Understand spoken as well as written Danish
- •Suffering from psoriasis vulgaris with a minimum of 4 plaques size 2-4 cm. in diameter located at arms, legs or body
- •Willingness to stop any systemic treatment of this condition during the test period – and 30 days prior to test start up
- •Willingness to pause any other treatment of the 4 plaques selected for the study 14 days prior to the test period - both creams and other treatments.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Must not suffer from any skin diseases that investigator finds will have influence on the outcome of the study – eigther with respect to the placement of the skin disease or the treatment of the skin disease
- •Must not suffer from diabetes mellitus
- •Must not be in systemic steroid treatment or have been so during the last 30 days prior to study start
研究者
相似试验
已完成
4 期
A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)Moderate Plaque PsoriasisNCT06333860AbbVie393
撤回
4 期
Optimizing the treatment of psoriasis with methotrexate; after 40 years the first dose-finding study.psoriasis10014982NL-OMON37246Academisch Medisch Centrum80
已完成
4 期
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic TherapyPsoriasisNCT04908475AbbVie352
已完成
4 期
Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp PsoriasisScalp PsoriasisGenital PsoriasisNCT05969223AbbVie214
已完成
2 期
A clinical trail to study the effects, safety and efficacy of Polyherbal formulations in patients with mild to moderate psoriasisCTRI/2010/091/000594APMC college pf pharmaceutical education & Research, Himatnagar20
